Which has the lower trailing P/E, ABBV or HUM?

HUM has the lower trailing P/E: ABBV trades at 72.43 and HUM at 38.81. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or HUM?

Over the past five years, HUM grew revenue faster — ABBV at a 3.69% CAGR versus HUM at 12.61%.

Does ABBV or HUM pay a bigger dividend?

ABBV yields 2.68% and HUM yields 0.88% based on trailing dividends and the latest price.

Is ABBV or HUM more profitable?

ABBV runs the higher net margin — ABBV at 9.81% versus HUM at 0.88%.

How have ABBV and HUM total returns compared?

Over the past 10 years, ABBV delivered 19.76% and HUM delivered 9.46% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Humana Inc. (HUM)

A side-by-side comparison of AbbVie Inc. and Humana Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

HUM

Humana Inc.

$49.21B

$409.85HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs HUM

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)HUM +147.2% (+9.5%/yr)ABBV compounded faster over this window

ABBV HUM

ABBV vs HUM: by the numbers

•ABBV is the larger company ($454.17B vs $49.21B market cap).
•HUM trades at the lower trailing earnings multiple (38.81 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•ABBV converts more revenue to profit (9.81% vs 0.88% net margin).
•HUM grew revenue faster over the past five years (12.61% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 0.88%).

Metrics side by side

Valuation

Metric	ABBV	HUM
P/E ratio	72.43	38.81
Forward P/E	18.32	44.77
P/S ratio	7.05	0.34
P/B ratio	N/A	2.56
EV / EBITDA	19.34	20.40
FCF yield	3.99%	N/A

Profitability

Metric	ABBV	HUM
Gross margin	71.48%	13.65%
Operating margin	29.32%	1.39%
Net margin	9.81%	0.88%
ROE	N/A	6.65%
ROIC	13.46%	4.52%

Dividends

Metric	ABBV	HUM
Dividend yield	2.68%	0.88%
Payout ratio	192.43%	33.52%

Growth (annualized)

Metric	ABBV	HUM
Revenue CAGR (5Y)	3.69%	12.61%
EPS CAGR (5Y)	-2.79%	-17.27%
FCF CAGR (5Y)	0.11%	-17.19%
Total return CAGR (5Y)	23.51%	0.94%

Frequently asked

Which has the lower trailing P/E, ABBV or HUM?: HUM has the lower trailing P/E: ABBV trades at 72.43 and HUM at 38.81. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or HUM?: Over the past five years, HUM grew revenue faster — ABBV at a 3.69% CAGR versus HUM at 12.61%.
Does ABBV or HUM pay a bigger dividend?: ABBV yields 2.68% and HUM yields 0.88% based on trailing dividends and the latest price.
Is ABBV or HUM more profitable?: ABBV runs the higher net margin — ABBV at 9.81% versus HUM at 0.88%.
How have ABBV and HUM total returns compared?: Over the past 10 years, ABBV delivered 19.76% and HUM delivered 9.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full HUM analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Humana P/E ratio AbbVie dividend yield Humana dividend yield AbbVie ROE Humana ROE AbbVie operating margin Humana operating margin AbbVie revenue growth Humana revenue growth AbbVie free cash flow Humana free cash flow

AbbVie & Humana appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest 10-Year Total Return Stocks Largest Companies by Market Cap

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.